IMARC Group, a leading market research company, has recently releases report titled “Intravenous (IV) Therapy and Vein Access Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033,” The study provides a detailed analysis of the industry, including the global intravenous (IV) therapy and vein access market size, share, trends, and growth forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights:
How big is the intravenous (IV) therapy and vein access market?
The global intravenous (IV) therapy and vein access market size reached USD 26.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 39.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4.4% during 2025-2033.
Browse full report with TOC List of Figures: https://www.imarcgroup.com/int....ravenous-therapy-vei
Factors Affecting the Growth of the Intravenous (IV) Therapy and Vein Access Industry:
Increasing Prevalence of Chronic Diseases:
The escalating prevalence of chronic diseases, including cancer, diabetes, and cardiovascular ailments, is a primary factor driving the market growth. Chronic diseases often necessitate long-term management, which frequently involves the administration of medications and fluids via intravenous (IV) routes. Furthermore, patients undergoing chemotherapy for cancer, insulin therapy for diabetes, or cardiovascular treatments rely on IV therapy for efficient drug delivery and management of their conditions. This has led to the heightened demand for reliable vein access devices such as catheters, infusion pumps, and needles. Moreover, the rising incidence of chronic diseases due to factors such as sedentary lifestyles and unhealthy dietary habits, leading to the increasing need for effective IV therapy solutions, is favoring the market growth.
Rising Geriatric Population:
The elevating geriatric population across the globe represents a significant factor driving the market growth. Advancing age comes with a higher prevalence of age-related health conditions, such as hypertension, arthritis, and cardiovascular diseases, which often require medical interventions involving IV therapy. Furthermore, geriatric individuals frequently undergo surgeries, treatments, and hospitalizations, during which reliable vein access becomes crucial for delivering medications, fluids, and nutrients effectively. Moreover, age-related physiological changes, such as decreased vein elasticity and integrity, which can pose challenges in venous access, necessitating the use of specialized devices and techniques, are driving the market growth.
Technological Advancements:
Continuous research and development (R&D) efforts, which have led to the introduction of advanced vein access devices equipped with features such as smart infusion pumps, integrated monitoring systems, and improved catheter materials, are boosting the market growth. These technological innovations aim to enhance the safety, efficacy, and convenience of IV therapy procedures for both patients and healthcare providers. Furthermore, the integration of wireless connectivity and digital interfaces in infusion pumps, which enables remote monitoring of infusion parameters, infusion rate adjustments, and early detection of potential complications, thereby improving patient outcomes and reducing healthcare costs, is positively impacting the market growth. Along with this, the development of catheter materials with enhanced biocompatibility and thromboresistance, which reduces the risk of catheter-related complications such as infections and thrombosis, is driving the market growth.
Request for a sample copy of this report: https://www.imarcgroup.com/int....ravenous-therapy-vei/requestsample
